Biological drugs are modern medical miracles. Derived from living organisms, this complex class of drugs — known as “biologics” — has proven astonishingly effective in treating a wide range of diseases, including rheumatoid arthritis, cancer, and a host of complex autoimmune disorders.
Thanks to the 2010 Patient Protection and Affordable Care Act, patients will soon have access to more affordable versions of these medicines. That legislation empowered the Food and Drug Administration to begin approving “biosimilars.”
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
